Antimicrobials & cholera: Are we stranded?

Indian Journal of Medical Research

Volumn 133, Issue 2, 2011, Pages 225-231

  Ghosh, Amit ^a   Ramamurthy, T ^a  

^a NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

Author keywords

Cholera; Genetic elements; Multidrug resistance; Resistance genes; V. Cholerae

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; ETHIDIUM; FURAZOLIDONE; GENTAMICIN; KANAMYCIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; SULFAMETHOXAZOLE; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; CHOLERA; DRUG RESEARCH; DRUG TARGETING; HUMAN; INTEGRON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; REVIEW; VIBRIO CHOLERAE; DRUG EFFECT; GENETICS; PATHOGENICITY;

ANTI-INFECTIVE AGENTS; CHOLERA; DRUG RESISTANCE, MICROBIAL; HUMANS; INTEGRONS; VIBRIO CHOLERAE;

EID: 79952980984     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. O'Grady F, Lewis MJ, Pearson NJ. Global surveillance of antibiotic sensitivity of Vibrio cholerae. Bull World Health Organ 1976; 54: 181-5.
2. Glass RI, Huq I, Alim AR, Yunus M. Emergence of multiply antibiotic-resistant Vibrio cholerae in Bangladesh. J Infect Dis 1980; 142: 939-42.
3. Phillips KF, Hailey FJ. The use of furoxone: a perspective. J Int Med Res 1986; 14: 19-29.
4. Baranwal S, Dey K, Ramamurthy T, Nair GB, Kundu M. Role of active efflux in association with target gene mutations in fluoroquinolone resistance in clinical isolates of Vibrio cholerae. Antimicrob Agents Chemother 2002; 46: 2676-8.
5. Rowe-Magnus DA, Guérout AM, Mazel D. Super-integrons. Res Microbiol 1999; 150: 641-51.
6. Dubois V, Debreyer C, Litvak S, Quentin C, Parissi V. A new in vitro strand transfer assay for monitoring bacterial class 1 integron recombinase IntI1 activity. PLoS One 2007; 2: e1315.
7. Guerin E, Cambray G, Sanchez-Alberola N, Campoy S, Erill I, Da Re S, et al. The SOS response controls integron recombination. Science 2009; 324: 1034.
8. Ghosh Amit, Ramamurthy T. Integron-mediated antimicrobial resistance in Vibrio cholerae. In: Ramamurthy T, Bhattacharya SK, editors. Epidemiological and molecular aspects on cholera. New York: Springer; 2010. p. 291-310.
9. Fonseca EL, Dos Santos Freitas F, Vieira VV, Vicente AC. New qnr gene cassettes associated with superintegron repeats in Vibrio cholerae O1. Emerg Infect Dis 2008; 14: 1129-31.
10. Kim HB, Wang M, Ahmed S, Park CH, LaRocque RC Faruque AS, et al. Transferable quinolone resistance in Vibrio cholerae. Antimicrob Agents Chemother 2010; 54: 799-803.
11. Burrus V, Marrero J, Waldor MK. The current ICE age: biology and evolution of SXT-related integrating conjugative elements. Plasmid 2006; 55: 173-83.
12. Burrus V, Waldor MK. Formation of SXT tandem arrays and SXT-R391 hybrids. J Bacteriol 2004; 186: 2636-45.
13. Amita, Chowdhury R, Thungapathra M, Ramamurthy T, Nair GB, Ghosh A. Class integrons and SXT elements in El Tor strains isolated before and after 1992 Vibrio cholerae O139 outbreak, Calcutta, India. Emerg Infect Dis 2003; 9: 500-2.
14. Burrus V, Quezada-Calvillo R, Marrero J, Waldor MK. SXT-related integrating conjugative element in New World Vibrio cholerae. Appl Environ Microbiol 2006; 72: 3054-7.
15. Beaber JW, Hochhut B, Waldor MK. SOS response promotes horizontal dissemination of antibiotic resistance genes. Nature 2004; 427: 72-4.
16. Sundaram S, Murthy KV. Transferable plasmid-mediated drug resistance among non-O1 Vibrio cholerae and rough strains of Vibrio cholerae from Tamilnadu, India. J Hyg (Lond) 1984; 92: 59-65.
17. Walther-Rasmussen J, Høiby N. Cefotaximases (CTX-M-17. ases), an expanding family of extended-spectrum beta-lactamases. Can J Microbiol 2004; 50: 137-65.
18. Corso A, Melano R, Cacace ML, Bru AM, Rossi A, et al. Plasmidic extended-spectrum beta-lactamases in Vibrio cholerae O1 El Tor isolates in Argentina. Antimicrob Agents Chemother 2002; 46: 1462-8.
19. Kuwahara S. Antibiotic resistance of 19. Vibrio cholerae: special consideration of R-plasmids. Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi 1978; 11: 99-103.
20. Rahal K, Gerbaud G, Bouanchaud DH. Stability of R plasmids belonging to different incompatibility groups in Vibrio cholerae ''El Tor''. Ann Mircobiol (Paris) 1978; 129: 409-14.
21. Yamamoto T, Nair GB, Takeda Y. Emergence of tetracycline resistance due to a multiple drug resistance plasmid in Vibrio cholerae O139. FEMS Immunol Med Microbiol 1995; 11: 131-6.
22. Kruse H, Sørum H, Tenover FC, Olsvik O. A transferable multiple drug resistance plasmid from Vibrio cholerae O1. Microb Drug Resist 1995; 1: 203-10.
23. Pan JC, Ye R, Wang HQ, Xiang HQ, Zhang W, Yu XF, et al. Vibrio cholerae O139 multiple-drug resistance mediated by Yersinia pestis pIP1202-like conjugative plasmids. Antimicrob Agents Chemother 2008; 52: 3829-36.
24. Bina XR, Provenzano D, Nguyen N, Bina JE. Vibrio cholerae RND family efflux systems are required for antimicrobial resistance, optimal virulence factor production, and colonization of the infant mouse small intestine. Infect Immun 2008; 76: 3595-605.
25. Colmer JA, Fralick JA, Hamood AN. Isolation and characterization of a putative multidrug resistance pump from Vibrio cholerae. Mol Microbiol 1998; 27: 63-72.
26. Singh AK, Haldar R, Mandal D, Kundu M. Analysis of the topology of Vibrio cholerae NorM and identification of amino acid residues involved in norfloxacin resistance. Antimicrob Agents Chemother 2006; 50: 3717-23.
27. Begum A, Rahman MM, Ogawa W, Mizushima T, Kuroda T, Tsuchiya T. Gene cloning and characterization of four MATE family multidrug efflux pumps from Vibrio cholerae non-O1. Microbiol Immunol 2005; 49: 949-57.
28. Woolley RC, Vediyappan G, Anderson M, Lackey M, Ramasubramanian B, Jiangping B, et al. Characterization of the Vibrio cholerae vceCAB multiple-drug resistance efflux operon in Escherichia coli. J Bacteriol 2005; 187: 5500-3.
29. Borges-Walmsley MI, Du D, McKeegan KS, Sharples GJ, Walmsley AR. VceR regulates the vceCAB drug efflux pump operon of Vibrio cholerae by alternating between mutually exclusive conformations that bind either drugs or promoter DNA. J Mol Biol 2005; 349: 387-400.
30. Yamaichi Y, Duigou S, Shakhnovich EA, Waldor MK. Targeting the replication initiator of the second Vibrio chromosome: towards generation of vibrionaceae-specific antimicrobial agents. PLoS Pathog 2009; 5: e1000663.
31. Bina XR, Philippart JA, Bina JE. Effect of the efflux inhibitors 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta naphthylamide on antimicrobial susceptibility and virulence factor production in Vibrio cholerae. J Antimicrob Chemother 2009; 63: 103-8.
32. Power E. Impact of antibiotic restrictions: the pharmaceutical perspectives. Clin Microbiol Infect 2006: 12 (Suppl 5): 25-34.
33. Projan SJ. Why is big pharma getting out of antibacterial drug discovery? Curr Opin Microbiol 2003; 6: 427-30.
34. Gottesman BS, Carmeli Y, Shitrit P, Chowers M. Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting. Clin Infect Dis 2009; 49: 869-75.
35. Okuda J, Ramamurthy T, Yamasaki S. The potent antibacterial activity of Sitafloxacin against fluoroquinolone-resistant clinical isolates of Vibrio cholerae O1. Microbiol Immunol 2007; 51: 467-9.
36. Roychoudhury S, Zielinski NA, Ninfa AJ, Allen NE, Jungheim LN, Nicas TI, et al. Inhibitors of two-component signal transduction systems: inhibition of alginate gene activation in Pseudomonas aeruginosa. Proc Natl Acad Sci USA 1993; 90: 965-9.
37. Waldor MK. Disarming pathogens - a new approach for antibiotic development. N Engl J Med 2006; 354: 296-7.
38. Hung DT, Shakhnovich EA, Pierson E, Mekalanos JJ. Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization. Science 2005; 310: 670-4.
39. WHO. Regional Strategy on Prevention and Containment and Antimicrobial resistance 2010-2015. Available from: http://www.searo.who.int/LinkFiles/BCT-htl-407.pdf, accessed on February 10, 2011.
40. Bhatia R, Narain JP. The growing challenge of antimicrobial resistance in the South-East Asian Region - Are we losing the battle? Indian J Med Res 2010; 132: 482-6.